Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRC-062 versus controlled-release hydromorphone in chronic non-cancer pain
ISRCTN54273961Phase 3Completed
- Sponsor
- Purdue Pharma
- Start
- Nov 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Chronic non-cancer pain (CNCP) comparing Controlled-release hydromorphone with PRC-062 (2 arms). Primary endpoint: Proportion requiring dose change. Started Nov 2013; status: completed.
02
Drugs
PRC-062hydromorphone
03
Conditions
Chronic non-cancer pain (CNCP)
Beyond the preview
Go deeper on ISRCTN54273961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN54273961.